Xlife Sciences AG (SWX:XLS)
Switzerland
· Delayed Price · Currency is CHF 19.70
+0.05 (0.25%)
At close: Jul 11, 2025, 5:20 PM CET
Xlife Sciences AG Market Cap
Xlife Sciences AG has a market cap or net worth of 113.11 million as of July 11, 2025. Its market cap has decreased by -35.82% in one year.
Market Cap
113.11M
Enterprise Value
263.60M
Revenue
834.88K
Ranking
n/a
PE Ratio
4.34
Stock Price
19.70
Market Cap Chart
Since February 10, 2022, Xlife Sciences AG's market cap has decreased from 240.46M to 113.11M, a decrease of -52.96%. That is a compound annual growth rate of -19.81%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 11, 2025 | 113.11M | -22.44% |
| Dec 30, 2024 | 145.84M | -47.72% |
| Dec 29, 2023 | 278.96M | 77.76% |
| Dec 30, 2022 | 156.93M | -34.74% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Roche Holding AG | 206.07B |
| Novartis AG | 188.54B |
| Lonza Group AG | 39.84B |
| Alcon | 34.64B |
| Galderma Group AG | 29.75B |
| Sandoz Group AG | 19.22B |
| Straumann Holding AG | 16.61B |
| Sonova Holding AG | 13.83B |